EUVIMEDOpdag EUVIMED
Leserbrief

Epstein–Barr Virus‐Positive Hemophagocytic Lymphohistiocytosis Following COVID‐19 Vaccination in a Pediatric Patient

Amanda Arand iD, Kathleen Overholt, Seethal A Jacob, Jennifer A Belsky iD

Pediatric Blood & Cancer · 2023

DOI: 10.1002/pbc.30189 ↗

At a glance

Leserbrief in Pediatric Blood & Cancer, 2023. Written by Amanda Arand and 3 co-authors. Institution: Indiana University School of Medicine, Indianapolis, Indiana, USA. Major MEDLINE topics: COVID-19, COVID-19 Vaccines, Epstein-Barr Virus Infections, Lymphohistiocytosis, Hemophagocytic. 9 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

To the Editor: Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of uncontrolled systemic inflammation, specifically global cytotoxic dysfunction1 identified by clinical and laboratory signs of immune activation. Secondary HLH is associated with underlying malignancy or infection; Epstein–Barr virus-associated HLH (EBV-HLH) is considered amajor subtype.2 The COVID-19 pandemic resulted in successful development of multiple mRNA vaccines against SARS-CoV-21. To date, aberrant activation of the immune response resulting in HLH in children has not been reported as an anticipated side effect. We present a case of a previously healthy adolescent who developed HLH complicated by EBV infection following his second COVID-19 vaccination. A previously healthy 17-year-old male presented with a 7-day history of headaches, nausea, and fever 2 weeks after his second COVID-19 vaccination. Hewas discharged home after laboratory testing demonstrated negative rapid EBV antibody and COVID antigen testing. His symptoms persistedwith daily fevers, new onset neck stiffness, dark urine, and listlessness. Day 14 of illness, he re-presented with fever, tachycardia, and hypotension. Physical exam revealed

Subjects

MeSH terms (MEDLINE)

COVID-19COVID-19 VaccinesEpstein-Barr Virus InfectionsLymphohistiocytosis, HemophagocyticChildHumansHerpesvirus 4, HumanVaccination

Substances

COVID-19 Vaccines

Authors and institutions

  • Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Marian University College of Osteopathic Medicine, Indianapolis, Indiana, USA.
  • Division of Hematology/Oncology, Riley Hospital for Children, Indianapolis, Indiana, USA.
  • Center for Pediatric and Adolescent Comparative Effectiveness Research, Indiana University, Indianapolis, Indiana, USA.

ORCID profiles: Amanda Arand, Jennifer A Belsky

Cite

APA

Arand, A., Overholt, K., Jacob, S. A., & Belsky, J. A. (2023). Epstein–Barr Virus‐Positive Hemophagocytic Lymphohistiocytosis Following COVID‐19 Vaccination in a Pediatric Patient. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30189

Vancouver

Arand A, Overholt K, Jacob SA, Belsky JA. Epstein–Barr Virus‐Positive Hemophagocytic Lymphohistiocytosis Following COVID‐19 Vaccination in a Pediatric Patient. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30189

BibTeX
@article{Arand2023,
  author = {Arand, Amanda and Overholt, Kathleen and Jacob, Seethal A and Belsky, Jennifer A},
  title = {Epstein–Barr Virus‐Positive Hemophagocytic Lymphohistiocytosis Following COVID‐19 Vaccination in a Pediatric Patient},
  journal = {Pediatric Blood & Cancer},
  year = {2023},
  doi = {10.1002/pbc.30189}
}
Start for free →